Adrian Ochoa1, Gabriel Patarroyo-Aponte1, Mahboob Rahman2. 1. Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA. 2. Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA. Mahboob.Rahman@uhhospitals.org.
Abstract
PURPOSE OF REVIEW: Central blood pressure is a novel predictor of cardiovascular risk that can be measured in the clinical setting using currently available technology. This paper will review current available methods of central blood pressure monitoring as well as its impact in cardiac and renal disease. RECENT FINDINGS: Both aortic and carotid systolic blood pressure are independently associated with cardiovascular mortality and serious cardiac events. Furthermore, studies show that systolic aortic blood pressure has been shown to be superior predictor of cardiovascular as compared to brachial blood pressure. Inhibitors of the renin angiotensin axis may have a beneficial effect on central blood pressure; however, long term studies evaluating the impact of lowering central blood pressure on clinical outcomes are lacking. Central blood pressure is a good predictor of cardiovascular risk. As more studies emerge demonstrating the value of central blood pressure as a therapeutic target, it is possible that targeting central blood pressure may become an important part of the armamentarium to lower cardiovascular risk.
PURPOSE OF REVIEW: Central blood pressure is a novel predictor of cardiovascular risk that can be measured in the clinical setting using currently available technology. This paper will review current available methods of central blood pressure monitoring as well as its impact in cardiac and renal disease. RECENT FINDINGS: Both aortic and carotid systolic blood pressure are independently associated with cardiovascular mortality and serious cardiac events. Furthermore, studies show that systolic aortic blood pressure has been shown to be superior predictor of cardiovascular as compared to brachial blood pressure. Inhibitors of the renin angiotensin axis may have a beneficial effect on central blood pressure; however, long term studies evaluating the impact of lowering central blood pressure on clinical outcomes are lacking. Central blood pressure is a good predictor of cardiovascular risk. As more studies emerge demonstrating the value of central blood pressure as a therapeutic target, it is possible that targeting central blood pressure may become an important part of the armamentarium to lower cardiovascular risk.
Entities:
Keywords:
Cardiovascular mortality; Central blood pressure; Monitoring
Authors: I B Wilkinson; I L Megson; T MacCallum; D F Rooijmans; S M Johnson; J L Boyd; J R Cockcroft; D J Webb Journal: J Cardiovasc Pharmacol Date: 2001-01 Impact factor: 3.105
Authors: Anthony M Dart; Christoph D Gatzka; Bronwyn A Kingwell; Kristyn Willson; James D Cameron; Yu-Lu Liang; Karen L Berry; Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; Trefor O Morgan; Malcolm J West Journal: Hypertension Date: 2006-02-27 Impact factor: 10.190
Authors: Riccardo Pini; M Chiara Cavallini; Vittorio Palmieri; Niccolò Marchionni; Mauro Di Bari; Richard B Devereux; Giulio Masotti; Mary J Roman Journal: J Am Coll Cardiol Date: 2008-06-24 Impact factor: 24.094
Authors: Isla S Mackenzie; Carmel M McEniery; Zahid Dhakam; Morris J Brown; John R Cockcroft; Ian B Wilkinson Journal: Hypertension Date: 2009-06-01 Impact factor: 10.190
Authors: Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson Journal: Eur Heart J Date: 2014-01-23 Impact factor: 29.983
Authors: James E Sharman; Alberto P Avolio; Johannes Baulmann; Athanase Benetos; Jacques Blacher; C Leigh Blizzard; Pierre Boutouyrie; Chen-Huan Chen; Phil Chowienczyk; John R Cockcroft; J Kennedy Cruickshank; Isabel Ferreira; Lorenzo Ghiadoni; Alun Hughes; Piotr Jankowski; Stephane Laurent; Barry J McDonnell; Carmel McEniery; Sandrine C Millasseau; Theodoros G Papaioannou; Gianfranco Parati; Jeong Bae Park; Athanase D Protogerou; Mary J Roman; Giuseppe Schillaci; Patrick Segers; George S Stergiou; Hirofumi Tomiyama; Raymond R Townsend; Luc M Van Bortel; Jiguang Wang; Siegfried Wassertheurer; Thomas Weber; Ian B Wilkinson; Charalambos Vlachopoulos Journal: Eur Heart J Date: 2017-10-01 Impact factor: 29.983
Authors: Claudia Rodriguez; Yueh-Yun Chi; Kuei-Hsun Chiu; Xiaoman Zhai; Melissa Lingis; Robert Stan Williams; Alice Rhoton-Vlasak; Wilmer W Nichols; John W Petersen; Mark S Segal; Kirk P Conrad; Rajesh Mohandas Journal: Physiol Rep Date: 2018-12
Authors: Azin Mousavi; Ali Tivay; Barry Finegan; Michael Sean McMurtry; Ramakrishna Mukkamala; Jin-Oh Hahn Journal: Front Physiol Date: 2019-08-06 Impact factor: 4.566
Authors: Magnus C Johansson; Anders Barasa; Carmen Basic; Gunnar Nyberg; Maria Schaufelberger Journal: Clin Physiol Funct Imaging Date: 2020-11-06 Impact factor: 2.273